Flow Diversion Embolization Device Reduces Thrombogenicity
By HospiMedica International staff writers Posted on 04 May 2021 |
Image: The Pipeline Flex embolization device with Shield Technology (Photo courtesy of Medtronic)
A proven flow diverter now features breakthrough biomaterial technology that modifies the implant surface to improve hemocompatibility.
The Medtronic (Dublin, Ireland) Pipeline Flex embolization device, developed 10 years ago, now includes Shield Technology, a modification of the surface implant in which a synthetic phosphorylcholine (PC) polymer is covalently-chemically-bonded to the strands of the device braid. The inert polymer mimics the outer membrane of a human red blood cell (RBC), so that other blood cells do not react to the braided cylindrical mesh tube.
“In addition to addressing material thrombogenicity, Shield Technology improves device performance by reducing the force required for both delivery and resheathing of the device,” said Dan Volz, president of the neurovascular business at Medtronic. “We believe that Shield Technology opens up a new range of options for physicians to continue to achieve improved patient outcomes, and we continue to challenge ourselves to deliver solutions that improve outcomes and increase value for all healthcare stakeholders.”
The third generation Pipeline Flex embolization device is designed to be placed in a parent vessel across the neck of an intracranial aneurysm (IA). Made of 48 braids, 36 of which are cobalt-chromium (CoCr) and 12 platinum wires for radiopacity, the implant provides approximately 30% metal coverage of the arterial wall surface area. In recent studies, Pipeline Flex with Shield Technology showed a strong record of safety and efficacy, with 77.2% complete aneurysm occlusion at 12 months, a 3.2% primary safety endpoint, and 93.1% complete wall apposition post-procedure.
Wide-neck IAs are defined as having a neck greater or equal to four mm, or a dome-to-neck ratio of less than two. They are often untreatable by surgical clipping, as many wide- neck aneurysms are in vessels deep within the brain that are not amendable to being treated by open brain surgery. Sufficiently dense coil packing of the AI to permanently exclude blood flow is also difficult to achieve. Flow diversion, on the other hand, is an endovascular technique whereby instead of placing a device inside the aneurysm sac, it is placed in the parent blood vessel to divert blood flow away from the aneurysm itself.
The Medtronic (Dublin, Ireland) Pipeline Flex embolization device, developed 10 years ago, now includes Shield Technology, a modification of the surface implant in which a synthetic phosphorylcholine (PC) polymer is covalently-chemically-bonded to the strands of the device braid. The inert polymer mimics the outer membrane of a human red blood cell (RBC), so that other blood cells do not react to the braided cylindrical mesh tube.
“In addition to addressing material thrombogenicity, Shield Technology improves device performance by reducing the force required for both delivery and resheathing of the device,” said Dan Volz, president of the neurovascular business at Medtronic. “We believe that Shield Technology opens up a new range of options for physicians to continue to achieve improved patient outcomes, and we continue to challenge ourselves to deliver solutions that improve outcomes and increase value for all healthcare stakeholders.”
The third generation Pipeline Flex embolization device is designed to be placed in a parent vessel across the neck of an intracranial aneurysm (IA). Made of 48 braids, 36 of which are cobalt-chromium (CoCr) and 12 platinum wires for radiopacity, the implant provides approximately 30% metal coverage of the arterial wall surface area. In recent studies, Pipeline Flex with Shield Technology showed a strong record of safety and efficacy, with 77.2% complete aneurysm occlusion at 12 months, a 3.2% primary safety endpoint, and 93.1% complete wall apposition post-procedure.
Wide-neck IAs are defined as having a neck greater or equal to four mm, or a dome-to-neck ratio of less than two. They are often untreatable by surgical clipping, as many wide- neck aneurysms are in vessels deep within the brain that are not amendable to being treated by open brain surgery. Sufficiently dense coil packing of the AI to permanently exclude blood flow is also difficult to achieve. Flow diversion, on the other hand, is an endovascular technique whereby instead of placing a device inside the aneurysm sac, it is placed in the parent blood vessel to divert blood flow away from the aneurysm itself.
Latest Surgical Techniques News
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room
- Future Muscle-Powered Surgical Robots Could Perform Minimally Invasive Procedures inside Body
- Non-Invasive Technique Combines Cardiac CT with AI-Powered Blood Flow for Heart Bypass Surgery
- First-Of-Its-Kind Device Repairs Leaky Tricuspid Heart Valve